Gene Query: GALT

Dataset Description Geneva Score
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 59.29
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 29.24
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 21.09
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 20.22
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 19.39
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 19.39
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 12.91
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 11.88
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 11.28
Evaluating pre-clinical models for studying NASH driven HCC. 11.02
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 10.95
RNA-seq of tumor cells following angiopellosis extravasation 10.69
RNA-seq of resting and activated CD4+ T cells +-JQ1 10.66
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 9.9
RNA-sequencing of human liver tissue 8.41
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 8.24
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 8.24
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 8.11
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 8.05
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 7.92
Transcriptome of activated human and mouse MAIT cells 7.87
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 7.74
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 7.7
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 7.61
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 7.61
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 7.52
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 7.36
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 7.36
Single-nucleotide-resolution mapping of HBV promoters using CAGE 7.28
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 7.23
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 7.04
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 6.94
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 6.86
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.78
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 6.72
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 6.64
Cleavage Factor Im as a key regulator of 3’ UTR length 6.58
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 6.5
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 6.49
Gene expression analysis of human liver progenitor-like cells in culture 6.37
Stem and effector CD8 T-cells from human cancers 6.28
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 6.28
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 6.17
mRNA expression profile of Lymphocytes by high-throuput sequencing 5.85
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 5.73
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 5.73
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 5.73
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 5.58
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.57
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 5.33
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 5.18
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.09
Noncoding regions are the main source of targetable tumor-specific antigens 5.09
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 5.08
Identification of renal resident macrophages across species [C1] 5.01
AUF-1 affected genes in human skin cells 4.91
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 4.87
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 4.83
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.64
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 4.57
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 4.55
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 4.53
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.49
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.49
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.47
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 4.46
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 4.42
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 4.35
Primary human trophoblast from term placenta 4.34
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 4.33
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 4.33
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 4.26
Gene expression signatures of innate lymphoid cells from human blood 4.07
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 4.02
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 4.0
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 3.95
RNA-seq in transgenic cells 3.95
RNA Seq of Alagille liver biopsies 3.88
Alagille_Nodder 3.88
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 3.87
Lysine benzoylation is a novel histone mark [RNA-seq] 3.78
Lysine benzoylation is a novel histone mark 3.78
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 3.78
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 3.75
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 3.72
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 3.7
MeRIP-seq for heat shock in B-cell lymphoma cells 3.67
CDK4/6 inhibitor resistance in prostate cancer 3.61
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 3.55
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 3.55
RNA-seq of IL-4 stimulated human keratinocytes 3.54
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 3.53
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 3.52
Single-cell analysis of human kidney organoids 3.51
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.51
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 3.47
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.46
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.46
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 3.42
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 3.42
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 3.42
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 3.41
CROP-Seq in Primary Human T Cells 3.4
Transcriptome analysis of CNS leukemia 3.4
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 3.4
Transciptomic profiling of human fetal lung samples 3.39
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 3.37
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 3.33
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 3.29
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 3.29
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 3.24
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.19
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 3.18
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 3.18
Postnatal lipids drive hepatocyte maturation 3.18
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 3.16
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 3.15
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 3.14
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 3.14
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 3.12
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 3.07
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 3.07
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 3.05
Transcriptome of Stabilin-1 siRNA transfected human monocytes 3.01
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 3.0
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 2.98
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 2.98
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 2.98
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 2.96
Unique features and clinical importance of acute alloreactive immune responses 2.95
naive T cell heterogeneity after neonatal thymectomy 2.91
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 2.89
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 2.88
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 2.88
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 2.88
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 2.87
Proliferation-correlated expression 2.87
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 2.82
Nonpregnant and term pregnant human myometrial tissues 2.82
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 2.82
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 2.81
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 2.8
Controlling for gene expression changes in transcription factor protein networks. 2.8
Gene expression changes after LOC550643 silencing 2.77
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 2.77
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 2.76
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 2.75
Identification of transcription start sites for human A549 cell line using ReCappable-seq 2.73
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 2.72
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 2.72
Pharmacologic inhibition of STAT5 in AML 2.72
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 2.69
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 2.68
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.67
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 2.67
Gene expression in GBM with Cav3.2 inhibition 2.66
Identification of global regulators of T-helper cell lineage specification 2.65
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 2.65
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.64
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 2.63
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 2.63
Identification of Sin3B regulated genes during quiescence 2.62
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 2.62
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 2.62
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 2.61
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.58
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 2.58
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 2.58
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 2.57
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.53
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 2.51
mRNA expression profile of Lymphocytes 2.5
Transcriptome analysis of virus infected tissues 2.49
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 2.48
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 2.47
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.45
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.44
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.44
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 2.43
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 2.43
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 2.43
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 2.43
Transcription control by the ENL YEATS domain in acute leukemia 2.43
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 2.4
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.39
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 2.37
Intrahepatic MAIT cell gene expression revealed by RNA-seq 2.37
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 2.34
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.32
LNCaP treated with iBET 2.32
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 2.32
RNA-Seq and expression data from human adipose tissue 2.31
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.31
RNAseq analysis of ESRP regulated splicing events in prostate cancer 2.31
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.31
NR2F2 study 2.31
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 2.31
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 2.31
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 2.29
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 2.27
Human Treg NaCl stimulation 2.27
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 2.26
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 2.26
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 2.26
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 2.25
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.22
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 2.22
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 2.22
Characterization of human ILC2 subsets 2.21
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 2.21
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 2.2
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.2
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 2.18
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 2.18
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 2.18
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 2.18
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 2.18
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 2.17
Identification of renal resident macrophages across species 2.17
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.16
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 2.15
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 2.14
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.12
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.11
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 2.08
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 2.07
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.07
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.06
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.06
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 2.05
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.04
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 2.03
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 2.02
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 2.01
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 2.01
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.01
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 2.0
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.99
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 1.98
Entrectinib Resistance in a Neuroblastoma Xenograft Model 1.94
A single cell reference map for human blood and tissue T cell activation 1.93
Identification of Atrial Fibrillation associated genes and functional non-coding variants 1.92
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.92
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.92
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.91
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.9
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 1.88
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.88
UV_24h_GRO-Seq 1.87
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.85
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 1.85
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 1.85
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 1.85
Expression by CD133+ cells isolated from the adult human exocrine pancreas 1.84
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.84
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.83
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.83
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 1.78
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.77
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.77
RNA-sequencing of formalin fixed human primary melanoma tissue 1.77
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.77
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.77
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.77
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 1.74
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 1.74
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 1.74
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.73
RNA-Seq from human ILC transitional populations 1.72
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.72
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.71
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.71
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.7
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.7
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 1.69
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 1.69
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 1.69
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.68
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.68
RNA-seq of naive and primed ES cells (NHSM) 1.68
Intron retention induced by microsatellite expansions as a disease biomarker. 1.67
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.67
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.67
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 1.66
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 1.66
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 1.66
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.66
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 1.66
Gene expression patterns define the hepatocyte-like cells derived by different strategies 1.66
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.64
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.64
Transcriptional effect of ETV1 knockdown in melanoma cells 1.63
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 1.63
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.62
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 1.61
Gene expression analysis of human hepatocellular cancers 1.61
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 1.61
Identification of a LIF-responsive replication-competent human β cell 1.6
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.59
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.59
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.58
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.56
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 1.55
quanTIseq: quantifying immune contexture of human tumors 1.53
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.53
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.53
Single-cell analysis of adult human ovary using 10X genomics 1.51
Expression analysis of the TAF1 syndrome 1.5
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 1.47
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 1.47
DRB/GRO-Seq -/+ UV 1.47
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 1.44
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.42
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.42
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.41
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 1.41
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 1.4
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 1.37
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 1.37
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.36
FOXP2's impact on the primate transcriptome 1.35
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 1.31
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 1.31
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.31
RNA seq with AML (NB4) cells upon FTO inhibition 1.3
Targeted enhancer activation by a subunit of the integrator complex 1.26
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 1.24
BACH2 in human plasma cell fate decision 1.23
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 1.23
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 1.23
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.21
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.21
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.2
Downregulation of DDX5/DDX17 and REST 1.19
Zone dependent distinctive gene expression profile of the normal human liver tissue 1.18
Loss of CREBBP results in gene expression repression in lymphoma cells 1.18
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.18
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.18
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 1.17
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 1.16
Transcriptome Profiling of Human Primary Monocytes 1.16
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 1.15
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.14
Transcriptomes in healthy and CHB fetal hearts 1.14
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.12
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.12
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.11
Dysregulated immune system networks in war veterans with PTSD 1.1
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 1.08
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.07
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.07
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.06
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.04
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 1.03
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 1.03
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.01
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.0
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.99
Survival of pancreatic cancer cells lacking KRAS function 0.95
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.95
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 0.94
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 0.94
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.93
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.93
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.93
Gene profiling of human adult and pediatric liver cancer cells 0.92
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.91
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.91
Expression patterns in chronic thromboembolic pulmonary hypertension 0.87
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.86
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.86
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.85
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.84
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.83
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.82
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.79
Gene expression analysis in response to hypoxic pathway inhibition 0.79
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.76
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.74
Regulation of poly(A) tail and translation during the somatic cell cycle 0.73
Repurposing of promoters and enhancers during mammalian evolution 0.73
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.72
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.72
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.71
RNAseq analysis of ruxolitinib treated breast cancers 0.69
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.69
Single-Cell Genotyping of Transcriptomes 0.69
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.68
RNA sequencing of T-ALL (COG study) 0.67
Analyses of T-ALL (COG study) 0.67
Transcriptome-wide modulation of splicing by the exon junction complex 0.67
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.65
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.65
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.64
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.62
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.6
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.6
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.6
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.59
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.58
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.58
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.57
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 0.56
MAIT cell RNA sequencing 0.55
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 0.54
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 0.54
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.54
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.53
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.53
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.52
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 0.51
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.49
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.49
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.48
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.47
Measure transcript integrity using RNA-seq data 0.46
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.43
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.43
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.43
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.43
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.42
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 0.42
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.42
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.41
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.41
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 0.38
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.38
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 0.37
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.36
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.36
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 0.36
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.34
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.34
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 0.33
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.33
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.33
HNRNPM-regulated splicing dependencies in prostate cancer 0.33
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.33
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.33
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.32
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 0.32
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.32
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.31
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.31
Regulatory network controlling tumor-promoting inflammation in human cancers 0.31
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 0.31
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.31
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.31
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.27
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.26
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.26
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.25
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.24
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.24
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.23
Function and hormonal regulation of GATA3 in human first trimester placentation 0.23
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.22
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.2
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.19
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.18
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.17
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.16
Hepatic transcriptome of pediatric hepatoblastoma. 0.16
U2AF1 mutations alter splice site recognition in hematological malignancies 0.16
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.15
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.15
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.14
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 0.14
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 0.14
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.14
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.14
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 0.14
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.14
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.14
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 0.13
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.13
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.13
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.13
ML29755 RNA-seq data 0.13
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.12
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.12
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.11
Deep RNA sequencing of the human placental transcriptome 0.11
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.1
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.09
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.09
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.09
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.08
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.08
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.07
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.06
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.05
miRNAs affected by antagomiR-17 treatment 0.04
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.04
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.03
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.03
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.03
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.01
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.0
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation